Literature DB >> 27435311

Influenza-associated thrombotic microangiopathy with unbalanced von Willebrand factor and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 levels in a heterozygous protein S-deficient boy.

Nobuyuki Tsujii1, Keiji Nogami2, Hiroyuki Yoshizawa1, Masaki Hayakawa3, Ayami Isonishi3, Masanori Matsumoto3, Midori Shima1.   

Abstract

Influenza infections often cause pneumonia, but there is limited information on thrombotic microangiopathy (TMA) in these circumstances. We report the case of an 11-year-old boy who developed TMA during the acute phase of H1N1 influenza. Plasma von Willebrand factor (VWF) was elevated, whereas a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity was mildly reduced in the absence of ADAMTS13-neutralizing autoantibody, resulting in low ratio of ADAMTS13 to VWF. The patient was treated intensively, including plasma exchange, and he recovered from the TMA. He developed pulmonary embolism (PE), however, after removal of the central venous catheter. The findings suggested that influenza-associated cytokines enhanced the release of unusually large VWF multimers from vascular endothelial cells and promoted the formation of platelet thrombi and TMA. Subsequent analysis further indicated the presence of familial protein S deficiency, and it seemed likely that the PE was more related to this heterozygous protein S defect.
© 2016 Japan Pediatric Society.

Entities:  

Keywords:  ADAMTS13; influenza; protein S deficiency; thrombotic microangiopathy; von Willebrand factor

Mesh:

Substances:

Year:  2016        PMID: 27435311     DOI: 10.1111/ped.13014

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  3 in total

1.  Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma.

Authors:  Christopher D Hamad; Zachary C Hoelscher; Amanda Tchakarov; Jaya Kala
Journal:  CEN Case Rep       Date:  2022-01-07

2.  Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Authors:  Eleni E Ladikou; Helena Sivaloganathan; Kate M Milne; William E Arter; Roshan Ramasamy; Ramy Saad; Simon M Stoneham; Barbara Philips; Alice C Eziefula; Timothy Chevassut
Journal:  Clin Med (Lond)       Date:  2020-07-21       Impact factor: 2.659

Review 3.  Influenza-associated thrombotic microangiopathies.

Authors:  Martin Bitzan; Jakub Zieg
Journal:  Pediatr Nephrol       Date:  2017-09-07       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.